Importantly, these studies have not established a clear dose-response relationship, and there is no consensus on a minimum effective dose for clinically meaningful GLP-1 stimulation
[3] The risk of cardiovascular events was non-significantly reduced to 0.76 (95% confidence interval [CI] 0.46-1.28) and the risk of all-cause mortality was non-significantly reduced to 0.78 (95% CI 0.40-1.51)
Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme , 46 (9), 11331142
doi: 10.1371/journal.pone.0175794 [DOI] [PMC free article] [PubMed] [Google Scholar] 26.Flattet Y, Garin N, Serratrice J, Perrier A, Stirnemann J, Carballo S
Even if medication is not currently a viable option, whether because of cost or conflicting factors, you can continue your weight loss journey